Cybin IRL Limited clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   EXTEND · CYB003 in MDD (EXTEND)

   Primary and study completion pushed from Mar 15, 2028 to Jun 6, 2028

   And 1 more change in the last 30 days

   Cybin IRL Limited·Phase 3· NCT06605105· Registry history of NCT06605105 on ClinicalTrials.gov (opens the registry)

   Updated Sep 25, 2026

2. Minor

   EMBRACE · Deuterated Psilocin Analog (CYB003) in Humans With…EMBRACE · Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

   Primary completion pushed from Mar 18, 2027 to Jun 7, 2027

   Also in this update: Trial sites expanded: 69 → 79 locations; Completion pushed from May 8, 2027 to Aug 9, 2027

   Cybin IRL Limited·Phase 3· NCT06793397· Registry history of NCT06793397 on ClinicalTrials.gov (opens the registry)

   Updated Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.